Pharmaceutical tablet

Description

The file of this patent contains at least one drawing executed in color. Copies of this patent with color drawings will be provided by the Office upon request and payment of the necessary fee.

FIG. 1 is a front perspective view of a pharmaceutical tablet showing our new design;

FIG. 2 is a top view thereof;

FIG. 3 is a right side view thereof, with the left side view thereof being identical thereto;

FIG. 4 is a bottom view thereof;

FIG. 5 is a front view thereof, with the rear view thereof being identical thereto;

FIG. 6 is a cross-sectional view through section 6--6 of FIG. 1;

FIG. 7 is a front perspective view of an alternate embodiment of the design of FIG. 1;

FIG. 8 is a top view thereof;

FIG. 9 is a right side view thereof, with the left side view thereof being identical thereto;

FIG. 10 is a bottom view thereof;

FIG. 11 is a front view thereof, with the rear view thereof being identical thereto;

FIG. 12 is a cross-sectional view through section 12--12 of FIG. 7;

FIG. 13 is a front perspective view of an alternate embodiment of the design of FIG. 1;

FIG. 14 is a top view thereof;

FIG. 15 is a right side view thereof, with the left side view thereof being identical thereto;

FIG. 16 is a bottom view thereof;

FIG. 17 is a front view thereof, with the rear view thereof being identical thereto;

FIG. 18 is a cross-sectional view through section 18--18 of FIG. 13;

FIG. 19 is a front perspective view of an alternate embodiment of the design of FIG. 1;

FIG. 20 is a top view thereof;

FIG. 21 is a right side view thereof, with the left side view thereof being identical thereto;

FIG. 22 is a bottom view thereof;

FIG. 23 is a front view thereof, with the rear view thereof being identical thereto; and,

FIG. 24 is a cross-sectional view through section 24--24 of FIG. 19.

The grayscale shading in FIGS. 19 24 depict a color contrast, and is not indicative of any specific color.

Claims

CLAIM The ornamental design for a pharmaceutical tablet, as shown and described.

---

Inventors:	Karolak; Wlodek (Mississauga, CA), Willy; Helen Anne (Harlow, GB)
Assignee:	Glaxo Group Limited (Middlesex, GB)
Appl. No.:	D/309,538
Filed:	August 28, 2008

---

Related U.S. Patent Documents

---

	Application Number	Filing Date	Patent Number	Issue Date
	29268559	Nov 9, 2006

---

Foreign Application Priority Data

---

May 12, 2006 [GB]			3024830

Current U.S. Class:	D24/101
Current International Class:	2801
Field of Search:	;D24/100-104 ;D28/4,8.1,8.2 ;424/464-482,453,438,732,451 ;D1/100,121,125-128,112,108 ;D21/440 ;426/78

---

References Cited [Referenced By]

---

U.S. Patent Documents

1419618	June 1922	Deming
1580576	April 1926	Edmund
2102885	December 1937	Carroll
2340037	January 1944	Irving
3048526	August 1962	Boswell
3620759	November 1971	Maddox
3702653	November 1972	Motten
D235215	May 1975	Larson
D258091	January 1981	Reed et al.
4376111	March 1983	Tovey
D269718	July 1983	Tovey
D269721	July 1983	Tovey
D269722	July 1983	Tovey
D274846	July 1984	Eoga
D283649	April 1986	Casberg
4601896	July 1986	Nugent
D285363	August 1986	Tovey
D286085	October 1986	Tovey
4643731	February 1987	Eckenhoff
4735805	April 1988	Ni et al.
4883182	November 1989	Hughes
D376643	December 1996	Hatton et al.
D420464	February 2000	Binstock et al.
D506545	June 2005	McAllister et al.
D520635	May 2006	Bonny et al.
D530814	October 2006	Bonny et al.
D535741	January 2007	Stawski et al.
7214396	May 2007	Rivier
D556946	December 2007	Seum et al.
D561992	February 2008	Linsley
D564086	March 2008	Nielsen et al.
D576776	September 2008	Klacik et al.

Other References

Karolak et al., U.S. Appl. No. 29/268,559, filed Nov. 9, 2006. cited by other.

Primary Examiner: Rademaker; Charles A
Assistant Examiner: Hanson; Charles D
Attorney, Agent or Firm: Nixon & Vanderhye P.C.